Bristol-Myers Squibb Company
4-AZAINDOLE COMPOUNDS

Last updated:

Abstract:

Disclosed are compounds of Formula (I) ##STR00001## N-oxides, or salts thereof, wherein G, A, R.sub.1, R.sub.5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

Status:
Application
Type:

Utility

Filling date:

26 Nov 2019

Issue date:

26 Mar 2020